Long-Term Outcomes and Prognosis of Transrectal High-Intensity Focused Ultrasound Therapy for Patients with Localized Prostate Cancer—Therapy after Recurrence and Predictive Factors
Objectives: To evaluate the outcomes and prognosis of high-intensity focused ultrasound (HIFU) therapy for patients with localized prostate cancer, and identify suitable candidates for this therapy by investigating the predictive factors. Methods: The 224 patients (low 54, intermediate 111 and high-risk patients 59) with T1-2 stage were treated using the Sonablate device and followed for over 12 months after treatment. Recurrence was determined based on histological findings, prostate-specific antigen (PSA) failure and local or distant metastasis. The factors which are predicting variables with potential effects were investigated by Kaplan-Meier and multivariate analysis. Results: A total of 255 treatment sessions (193 with one, 31 with two) were performed. No patients died of prostate cancer, but 15 died of other causes and 14 patients were lost during follow-up. The 7-year recurrence-free survival (RFS) rates in all patients were 75%, and 5-year RFS rates were 98%, 84% and 59% in the low, intermediate and high-risk patients respectively. In the 216 patients who underwent histological examination at 6 months or later after HIFU, 25 (12%) were positive. In 77 patients with recurrence after first-HIFU, the second treatments were hormonal therapy and HIFU. Of the 31 patients who underwent a second HIFU, the 5-year RFS rates were 64%, and 5-year RFS rates were 100%, 74% and 33% in the low, intermediate and high-risk patients. The significant predictor for recurrence was risk-group, T-stage (T1 vs T2), Gleason score (≤3 + 4 and ≥4 + 3), pretreatment PSA (<10 vs ≥10 ng/ml) and nadir PSA (<0.1 vs ≥0.1 ng/ml). In 111 patients with intermediate-risk, T-stage and nadir PSA were significantly associated with outcomes. Conclusions: Prognosis of HIFU for Patients with localized prostate cancer was good, and the low and intermediate-risk patients with T1-staging are suitable indications for HIFU. Effective predictors for outcomes were risk-group, T-stage, Gleason score, pretreatment PSA and nadir PSA.
References
[1]
Namiki, S., Ishidoya, S., Ito, A., Kawamura, S., Tochigi, T., Saito, S. and Arai, Y. (2009) Quality of Life after Radical Prostatectomy in Japanese Men: A 5-Year Follow up Study. International Journal of Urology, 16, 75-81.
http://onlinelibrary.wiley.com/doi/10.1111/j.1442-2042.2008.02197.x/abstract
https://doi.org/10.1111/j.1442-2042.2008.02197.x
[2]
Verze, P., Scuzzarella, S., Martina, G.R., Giummelli, P., Cantoni, F. and Mirone, V. (2013) Long-Term Oncological and Functional Results of Extraperitoneal Laparoscopic Radical Prostatectomy: One Surgical Team’s Experience on 1,600 Consecutive Cases. World Journal of Urology, 31, 529-534.
http://link.springer.com/article/10.1007%2Fs00345-013-1052-0
https://doi.org/10.1007/s00345-013-1052-0
[3]
Busch, J., Stephan, C., Herold, A., Erber, B., Kempkensteffen, C., Hinz, S., Lein, M., Weikert, S., Miller, K. and Magheli, A. (2012) Long-Term Oncological and Continence Outcomes after Laparoscopic Radical Prostatectomy: A Single-Centre Experience. BJU International, 110, E985-990.
http://onlinelibrary.wiley.com/doi/10.1111/j.1464-410X.2012.11279.x/abstract
https://doi.org/10.1111/j.1464-410X.2012.11279.x
[4]
Odrazka, K., Dolezel, M., Vanasek, J., Vaculikova, M., Zouhar, M., Sefrova, J.l., Paluska, P., Vosmik, M., Kohlova, T., Kolarova, I., Navratil, P., Brodak, M., Prosvic, P. and Hoffmann, P. (2010) Late Toxicity after Conformal and Intensity-Modulated Radiation Therapy for Prostate Cancer: Impact of Previous Surgery for Benign Prostatic Hyperplasia. International Journal of Urology, 17, 784-790.
http://onlinelibrary.wiley.com/doi/10.1111/j.1442-2042.2010.02592.x/abstract
https://doi.org/10.1111/j.1442-2042.2010.02592.x
[5]
Vora, A.V., Wong, W.W., Schild, S.E., Ezzell, G.A., Andrews, P.E., Ferrigni, R.G. and Swanson, S.K. (2013) Outcome and Toxicity for Patients Treated with Intensity Modulated Radiation Therapy for Localized Prostate Cancer. The Journal of Urology, 190, 521-526.
http://www.jurology.com/article/S0022-5347(13)00279-6/abstract
https://doi.org/10.1016/j.juro.2013.02.012
[6]
Zelefsky, M.J., Kuban, D.A., Levy, L.B., Potters, L., Beyer, D.C., Blasko, J.C., Moran, B.J., Ciezki, J.P., Zietman, A.L., Pisansky, T.M., Elshaikh, M. and Horwits, E.M. (2007) Multi-Institutional Analysis of Long-Term Outcome for stageT1-T2 Prostate Cancer Treated with Permanent Seed Implantation. International Journal of Radiation Oncology, Biology, Physics, 67, 327-333.
http://www.redjournal.org/article/S0360-3016(06)02817-3/abstract
https://doi.org/10.1016/j.ijrobp.2006.08.056
[7]
Cohen, J.K., Miller, R.J., Ahmed, S., and Baust, J. (2008) Ten-Year Biochemical Disease Control for Patients with Prostate Cancer Treated with Cryosurgery as Primary Therapy. Urology, 71, 515-518.
http://www.goldjournal.net/article/S0090-4295(07)02193-0/abstract
https://doi.org/10.1016/j.urology.2007.09.059
[8]
Maderbacher, S., Pedevilla, M., Vinger, L., Susani, M. and Marberger, M. (1955) Effect of High-Intensity Focused Ultrasound on Human Prostate Cancer in Vivo. Cancer Research, 55, 3346-3351.
http://cancerres.aacrjournals.org/content/55/15/3346.long
[9]
Gelet, A., Chapelon, J.Y., Bouvier, R., Rouviere, O., Lasne, Y., Lyonnet, D. and Dubernard, J.M. (2000) Transrectal High-Intensity Focused Ultrasound: Minimally Invasive Therapy of Localized Prostate Cancer. Journal of Endourology, 14, 519-528. https://www.ncbi.nlm.nih.gov/pubmed/10954310
https://doi.org/10.1089/end.2000.14.519
[10]
Inoue, Y., Goto, K., Hayashi, T. and Hayashi, M. (2011) Transrectal High-Intesity Focused Ultrasound for Treatment of Localized Prostate Cancer. International Journal of Urology, 18, 358-362.
http://onlinelibrary.wiley.com/doi/10.1111/j.1442-2042.2011.02739.x/abstract
https://doi.org/10.1111/j.1442-2042.2011.02739.x
[11]
Hayashi, M., Oka, K. and Inoue, K. (2015) Long-Term Outcomes of Transrectal High-Intensity Focused Ultrasound for Localized Prostate Cancer. Japanese Journal of Endourology, 28, 322-330.
https://www.jstage.jst.go.jp/article/jsejje/28/2/28_322/_article
[12]
D’Amico, A.V., Whittington, R., Malkowicz, S.B., Schults, D., Blank, K., Broderick, G.A., Tomaszewski, J.E., Renshaw, A.A., Kaplan, I., Beard, C.J. and Wein, A. (1998) Biochemical Outcome after Radical Prostatectomy, External Beam Radiation Therapy, or Interstitial Radiation Therapy for Clinically Localized Prostate Cancer. The Journal of the American Medical, 280, 969-974.
http://jamanetwork.com/journals/jama/fullarticle/187980
https://doi.org/10.1001/jama.280.11.969
[13]
Roach, M., Hanks, G., Thames, H., Schellhammer, P., Shipley, W.U., Sokol, G.H. and Sandler, H. (2006) Defining Biochemical Failure Following Radiotherapy with or without Hormonal Therapy in Men with Clinically Localized Prostate Cancer: Recommendations of the RTOG-ASTRO Phoenix Conference. International Journal of Radiation Oncology, Biology, Physics, 65, 965-974.
http://www.redjournal.org/article/S0360-3016(06)00663-8/abstract
https://doi.org/10.1016/j.ijrobp.2006.04.029
[14]
Thuroff, S., Chaussy, C., Vallancien, G., Wieland, W., Kiel, H.J., Duc, A.L., Desgrandchamps, F., Rosette, J.D.L. and Gelet, A. (2003) High-Intensity Focused Ultrasound and Localized Prostate Cancer: Efficacy Results from the European Multicentric Study. Journal of Endourology, 17, 673-677.
http://online.liebertpub.com/doi/abs/10.1089/089277903322518699
https://doi.org/10.1089/089277903322518699
[15]
Blana, A., Walter, B., Rogenhofer, S. and Wieland, W. (2004) High-Intensity Focused Ultrasound for the Treatment of Localized Prostate Cancer: 5-Year Experience. Urology, 63, 297-300.
http://www.goldjournal.net/article/S0090-4295(03)01008-2/abstract
https://doi.org/10.1016/j.urology.2003.09.020
[16]
Uchida, T., Shoji, S., Nakano, M., Hongo, S., Nitta, M., Murota, A. and Nagata, Y. (2009) Transrectal High-Intensity Focused Ultrasound for the Treatment of Localized Prostate Cancer; Eight-Year Experience. International Journal of Urology, 16, 881-886. http://onlinelibrary.wiley.com/doi/10.1111/j.1442-2042.2009.02389.x/abstract
https://doi.org/10.1111/j.1442-2042.2009.02389.x
[17]
Baco, E., Gelet, A., Crouzet, S., Rud, E., Rouviere, O., Tonoli-Catez, H., Berge, V., Chapelon, J.Y. and Eggesbo, H.B. (2014) Hemi Salvage High-Intensity Focused Ultrasound (HIFU) in Unilaterall Radiorecuuent Prostate Cancer: A Prospective Two-Centre Study. BJU International, 114, 532-540.
http://onlinelibrary.wiley.com/doi/10.1111/bju.12545/abstract
https://doi.org/10.1111/bju.12545
[18]
Shoji, S., Mouraviev, V. and Scionti, S. (2016) High-Intensity Focused Ultrasound Treatment. Handbook of Focal Therapy for Prostate and Renal Cancer, 241-254.
[19]
Ganzer, R., Fritsche, H.M., Brandtner, A., Brundl, J., Koch, D., Wieland, W.F. and Blana, A. (2013) Fourteen-Year Oncological and Functional Outcomes of High-Intensity Focused Ultrasound in Localized Prostate Cancer. BJU International, 112, 322-329.
http://onlinelibrary.wiley.com/doi/10.1111/j.1464-410X.2012.11715.x/abstract
https://doi.org/10.1111/j.1464-410X.2012.11715.x
[20]
Crouzet, S., Chapelon, J.Y., Rouviere, O., Mege-Lechevallier, F., Colombel, M., Tonoli-Catez, H., Martin, X. and Gelet, A. (2014) Whole-Gland Ablation of Localized Prostate Cancer with High-Intensity Focused Ultrasound Oncologic Outcomes and Morbidity in 1002 Patients. European Urology, 65, 907-914.
http://www.europeanurology.com/article/S0302-2838(13)00424-7/abstract
https://doi.org/10.1016/j.eururo.2013.04.039
[21]
Uchida, T., Tomonaga, T., Kim, H., Nakano, M., Shoji, S., Nagata, Y. and Terachi, T. (2015) Improved Outcomes with Advancements in High Intensity Focused Ultrasound Devices for the Treatment of Localized Prostate Cancer. The Journal of Urology, 193, 103-110.
http://www.jurology.com/article/S0022-5347(14)04047-6/abstract
https://doi.org/10.1016/j.juro.2014.07.096
[22]
Menon, M., Bhandari, M., Gupta, N., Lane, Z., Peabody, J.O., Rogers, C.G., Sammon, J., Siddiqui, S.A. and Diaz, M. (2010) Biochemical Recurrence Following Robot-Assisted Radical Prostatectomy: Analysis of 1384 Patients with A Median 5-Year Follow-Up. European Urology, 838-846.
http://eu-acme.org/europeanurology/upload_articles/Sammon.pdf
https://doi.org/10.1016/j.eururo.2010.09.010
[23]
Lukka, H., Waldron., T., Chin, J., Mayhew, L., Warde, P., Winquist, E., Rodrigues, G. and Shayegan, B. (2011) High-Intensity Focused Ultrasound for Prostate Cancer: A Systematic Review. Clinical Oncology, 23, 117-127.
http://www.clinicaloncologyonline.net/article/S0936-6555(10)00372-9/pdf
https://doi.org/10.1016/j.clon.2010.09.002
[24]
Uchida, T., Nakano, M., Hongo, S., Shoji, S., Nagata, Y., Satoh, T., Baba, S., Usui, Y. and Terachi, T. (2012) High-Intensity Focused Ultrasound Therapy for Prostate Cancer. International Journal of Urology, 19, 187-201.
http://onlinelibrary.wiley.com/doi/10.1111/j.1442-2042.2011.02936.x/abstract
https://doi.org/10.1111/j.1442-2042.2011.02936.x
[25]
Blana, A., Brown, S.C.W., Chaussy, C., Conti, G.N., Eastham, J.A., Ganzer, R., Murat, F.J., Pasticier, G., Rebillard, X., Rewcastle, J.C., Robertson, C.N., Thuroff, S. and Ward, J.F. (2009) High-Intensity Focused Ultrasound for Prostate Cancer: Comparative Definitions of Biochemical Failure. BJU International, 104, 1058-1062.
http://onlinelibrary.wiley.com/doi/10.1111/j.1464-410X.2009.08518.x/abstract
https://doi.org/10.1111/j.1464-410X.2009.08518.x
[26]
Mearini, L., D’Urso, L., Collura, D., Zucchi, A., Costantini, E., Formiconi, A., Bini, V., Muto, G. and Porena, M. (2008) Visually Directed Transrectal High Intensity Focused Ultrasound for the Treatment of Prostate Cancer : A Preliminary Report on the Italian Experience. The Journal of Urology, 181, 105-112.
http://www.jurology.com/article/S0022-5347(08)02444-0/abstract
https://doi.org/10.1016/j.juro.2008.09.024
[27]
Thuroff, S. and Chaussy, C. (2013) Evolution and Outcomes of 3 MHz High Intensity Focused Ultrasound Therapy for Localized Prostate Cancer During 15 Years. The Journal of Urology, 190, 702-710.
http://www.jurology.com/article/S0022-5347(13)00277-2/abstract
https://doi.org/10.1016/j.juro.2013.02.010
[28]
Crouzet, S., Rebillard, X., Chevallir, D., Rischmann, P., Pasticier, G., Garcia, G., Rouvier, O., Chapelon, J.Y. and Gelet, A. (2010) Multicentric Oncologic Outcomes of High-Intensity Focused Ultrasound for Localized Prostate Cancer in 803 Patients. European Urology, 58, 559-566.
http://www.europeanurology.com/article/S0302-2838(10)00596-8/pdf
https://doi.org/10.1016/j.eururo.2010.06.037
[29]
Sumitomo, M., Hayashi, M., Watanabe, T., Tsugawa, M., Noma, H., Yamaguchi, A., Nagakura, K., Hayakawa, M. and Uchida, T. (2008) Efficacy of Short-Term Androgen Deprivation with High-Intensity Focused Ultrasound in the Treatment of Prostate Cancer in Japan. Urology, 72, 1335-1340.
http://www.goldjournal.net/article/S0090-4295(07)02613-1/abstract
https://doi.org/10.1016/j.urology.2007.12.041
